HIV & Aging Clinical Recommendations

CME/CE Info

HIV & Aging Clinical Recommendations

CME/CE credit available August 1, 2019 – March 30, 2020
Estimated time to complete all chapters: 14.25 hours
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and American Academy of HIV Medicine, in collaboration with Postgraduate Institute for Medicine

 

 

 

This activity is supported by independent educational grants from Gilead Sciences, Inc. and Janssen Therapeutics, Division of Janssen Products, LP.

Target Audience

This activity is intended for physicians and pharmacists and other healthcare providers who treat, diagnose and refer older patients with HIV disease.

Faculty – listed under “About/Who We Are

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and American Academy of HIV Medicine. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates these enduring materials for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These programs have been developed according to the ACPE Criteria for Quality and is assigned the ACPE UANs noted below. These programs are designated for up to 15 contact hours (1.5 CEUs) of the Accreditation Council for Pharmacy Education.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period August 1, 2019 through March 30, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 12666. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.

Chapter 1 – Assessing Frailty and Functional Capacity: Managing the care of older adults with HIV
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-050-H02-P; knowledge
Learning Objective:

  • Identify different ways of assessing frailty in people living with HIV.
     

Chapter 2 – Detection and Screening for HIV in Older Adults
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-067-H02-P; knowledge
Learning Objectives:

  • Describe the CDC guidelines for screening for HIV.
  • Compare and contrast barriers to screening.
     

Chapter 3 – When to Initiate Antiretrovial Therapy and Monitoring in HIV and Aging
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-068-H02-P; knowledge
Learning Objective:

  • Give the indications to offer antiretroviral therapy (ART) in an older adult (>50 years) living with HIV and describe the challenges seen in older adults on ART.
     

Chapter 4 – Immunizations in HIV and Aging
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-069-H02-P; knowledge
Learning Objective:

  • State what vaccines are contraindicated in HIV-infected patients with advanced immunodeficiency and also where to find the CDC guidelines for vaccination in immunocompromised hosts, which includes HIV.
     

Chapter 5 – CVD Screening and Prevention
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-070-H02-P; knowledge
Learning Objectives:

  • Describe factors that contribute to increased risk for CVD in aging individuals with HIV.
  • Describe strategies for CVD risk assessment.
     

Chapter 6 – Chronic Obstructive Pulmonary Disease in HIV and Aging
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-0718-H02-P; knowledge
Learning Objective:

  • Recognize the increased risk of COPD development and progression in HIV-infected patients and the impact this disease has on patient function and survival.
     

Chapter 7 – Smoking
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-072-H04-P; knowledge
Learning Objectives:

  • Describe the increased cardiovascular risk with smoking in a patient with HIV.
  • Describe strategies to help patients with HIV stop smoking.
     

Chapter 8 – The Kidney in HIV and Aging
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-073-H02-P; knowledge
Learning Objective:

  • Outline risk factors for chronic kidney disease (CKD) in HIV-infected patients.
     

Chapter 9 – Hypertension in HIV and Aging
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-074-H04-P; knowledge
Learning Objectives:

  • Define optimizing BP for older patients with HIV.
  • Modify the BP target for those with hypotension.
  • Apply general treatment guidelines, selecting appropriate anti-hypertensive medications.
     

Chapter 10 – Cancer in HIV and Aging
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-075-H02-P; knowledge
Learning Objective:

  • Describe incidence and virulence of Non-AIDS cancers in people living with HIV and understand cancer screening guidelines for older adults with HIV.
     

Chapter 11 – Viral Hepatitis
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-076-H02-P; knowledge
Learning Objective:

  • Discuss the importance of viral hepatitis screening for individuals with HIV.
     

Chapter 12 – Diabetes Mellitus in HIV and Aging
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-077-H01-P; knowledge
Learning Objectives:

  • Describe interventions that may prevent the development of diabetes mellitus.
  • Relate the target glycosylated hemoglobin for older patients with HIV and diabetes.
     

Chapter 13 – Polypharmacy in HIV and Aging
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-078-H02-P; knowledge
Learning Objective:

  • Outline two adverse effects of polypharmacy on the health of HIV-infected patients.
     

Chapter 14 – Osteoporosis in HIV and Aging
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-079-H02-P; knowledge
Learning Objective:

  • Describe two features that distinguish osteoporosis in HIV-infected patients from that in the general population.
     

Chapter 15 – Sexual Health
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-080-H02-P; knowledge
Learning Objectives:

  • Support the need for the health care team to address high-risk sexual behavior in their patients on a regular basis.
  • Internalize data indicating their comprehension of the fact that sexual activity in older adults occurs at high frequency. That awareness will provide a better basis to respond to requests for erectile dysfunction medications in men and estrogen products for vaginal dryness in women.
  • Review the need to couple this with a discussion of safe sex practices.
  • Provide the health care team with practical advice on framing questions to start a dialogue with patients on sexual health.
     

Chapter 16 – PrEP and the Older Adult with HIV
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-081-H02-P; knowledge
Learning Objectives:

  • Provide the rationale for the use of PrEP (Pre-Exposure Prophylaxis) to reduce new HIV infections in older adults.
  • Consider the importance of the older adult with HIV becoming a conduit to provide information and encouragement for PrEP use in sexual partners and other older adults.
     

Chapter 17 – Nutrition
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-082-H02-P; knowledge
Learning Objective:

  • Demonstrate an understanding of the relationship between nutrition and health outcomes in aging individuals with HIV.
     

Chapter 18 – Depression in HIV and Aging
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-083-H02-P; knowledge
Learning Objectives:

  • Review depression and co-morbidity in older patients with HIV.
  • Discuss the risk taking behavior associated with depression.
  • Apply depression screening tools for most efficacious interventions.
     

Chapter 19 – Anxiety Disorders in HIV and Aging
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-084-H02-P; knowledge
Learning Objectives:

  • Define the frequency of anxiety disorders in adults with HIV infection.
  • Discuss the preferred behavioral approaches to treatment.
  • Review the options for psychopharmacotherapy.
     

Chapter 20 – Substance Use Disorders
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-085-H02-P; knowledge
Learning Objective:

  • Recognize the burden of substance use disorder in HIV infected adults above 50 years of age and how the treatment of this disorder is done in a comprehensive care model that integrates behavioral health services with medical treatment.
     

Chapter 21 – HIV-1 Associated Peripheral Neuropathologies in HIV and Aging
Physicians – maximum of 0.75 AMA PRA Category 1 Credits
Pharmacists – 0.75 contact hours (0.075 CEUs)
ACPE UAN: 0797-9999-19-086-H02-P; knowledge
Learning Objective:

  • Name the most common type of HIV-1 associated peripheral neuropathy, its symptomatology and evidenced based treatment options.
     

Chapter 22 – Older Age and Associated Neurocognitive Disorder (HAND)
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-087-H02-P; knowledge
Learning Objective:

  • Describe three categories of HIV-associated neurocognitive disorders (HAND).
     

Chapter 23 – Advanced Care Planning
Physicians – maximum of 0.5 AMA PRA Category 1 Credits
Pharmacists – 0.5 contact hours (0.05 CEUs)
ACPE UAN: 0797-9999-19-088-H02-P; knowledge
Learning Objective:

  • Explain the importance of advanced care planning as standard practice for HIV-infected patients.

Disclosure of Conflicts of Interest

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty
Jonathan Appelbaum – Consulting Fees: Merck; ViiV
Kristina Crothers – nothing to disclose
Marshall Forstein – nothing to disclose
Meredith Greene – nothing to disclose
Amy Caroline Justice – nothing to disclose
Stephen Karpiak – nothing to disclose
Jeffrey Kwong – Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (eg: Speakers Bureau): Gilead Sciences, Inc.
Katherine Schafer – nothing to disclose
James Scott – nothing to disclose
Charlie Smigelski – nothing to disclose
James Sosman – nothing to disclose
David Spach – nothing to disclose
Mehul Tejani – nothing to disclose
Nathan Wass – nothing to disclose
Pariya Fazeli Wheeler – nothing to disclose
Brian Wood – nothing to disclose

Planners and Managers
Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education and Alma Perez, Accreditation Specialist,both from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose. The AAHIVM planners and managers have nothing to disclose.

Media

Internet

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Purpose of this Program: The AAHIVM, ACRIA and AGS (collectively, the “Sponsors,” “we” or “us”) are sponsors of this Website and through it seek to address the unique needs and challenges that older adults of diverse populations living with HIV face as they age. However, the information in this Website is not meant to supplant the advice provided in a doctor-patient relationship.

General Disclaimer: HIV-Age.org is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through HIV-Age.org should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1705 DeSales Street NW, Suite 700
Washington, D.C. 20036

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.